BRAF and thyroid cancer: Five studies used only patients with differentiated thyroid cancers (DTC),50, 53, 55, 56, 57 two used patients with BRAF V600 E mutation thyroid cancer,20, 58 one in patients with PTC22 and one in patients with APC.27